NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / â?¯Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc.â?¯("Tempus" or the "Company") (NASDAQ:TEM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comâ?¯or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to […]

NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ:RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation ("Vestis" or the "Company") (NASDAQ:VSTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK, NY / ACCESS Newswire / July 21, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=157524&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc ("Reckitt" or the "Company") (OTCMKTS:RBGLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail

NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Broadmark Realty Capital Inc. ("Broadmark" or the "Company") (NYSE:BRMK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail

NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co.â?¯("Organon" or the "Company") (NYSE:OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comâ?¯or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against DoubleVerify Holdings, Inc. ("DoubleVerify" or the "Company") (NYSE:DV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NORTH BILLERICA, MA / ACCESS Newswire / July 21, 2025 / Tecogen Inc. ("Tecogen" or "Company"), (NYSE American:TGEN), a leading manufacturer of clean energy products, today announced the closing of its previously announced underwritten public offering of 3,985,000 shares of common stock, including the full exercise by the underwriter of its option to purchase an

NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE:ANRO) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-06105,